Coccidioides species antifungal susceptibility testing: Experience from a large healthcare system in the endemic region

Tirdad T. Zangeneh; William D. Lainhart; Nathan P. Wiederhold; Mohanad M. Al-Obaidi

doi:10.1093/mmy/myad104

Coccidioides species antifungal susceptibility testing: Experience from a large healthcare system in the endemic region

Tirdad T. Zangeneh, William D. Lainhart, Nathan P. Wiederhold, Mohanad M. Al-Obaidi

Research output: Contribution to journal › Article › peer-review

Abstract

The clinical utility of Coccidioides species antifungal susceptibility testing (AST) remains unclear. This study describes the clinical course of eight patients with severe or chronic coccidioidomycosis and subsequent Coccidioides AST. We present the clinical manifestations, antifungal treatment regimens, and clinical outcomes for these patients.

Original language	English (US)
Article number	myad104
Journal	Medical mycology
Volume	61
Issue number	10
DOIs	https://doi.org/10.1093/mmy/myad104
State	Published - Oct 1 2023

Keywords

antifungal susceptibility
antifungal therapy
coccidioidomycosis

ASJC Scopus subject areas

Infectious Diseases

Access to Document

10.1093/mmy/myad104

Cite this

@article{5d69173ce1d64ba8947ee4bb7d15a379,

title = "Coccidioides species antifungal susceptibility testing: Experience from a large healthcare system in the endemic region",

abstract = "The clinical utility of Coccidioides species antifungal susceptibility testing (AST) remains unclear. This study describes the clinical course of eight patients with severe or chronic coccidioidomycosis and subsequent Coccidioides AST. We present the clinical manifestations, antifungal treatment regimens, and clinical outcomes for these patients.",

keywords = "antifungal susceptibility, antifungal therapy, coccidioidomycosis",

author = "Zangeneh, {Tirdad T.} and Lainhart, {William D.} and Wiederhold, {Nathan P.} and Al-Obaidi, {Mohanad M.}",

note = "Publisher Copyright: {\textcopyright} 2023 The Author(s). Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.",

year = "2023",

month = oct,

day = "1",

doi = "10.1093/mmy/myad104",

language = "English (US)",

volume = "61",

journal = "Medical mycology",

issn = "1369-3786",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - Coccidioides species antifungal susceptibility testing

T2 - Experience from a large healthcare system in the endemic region

AU - Zangeneh, Tirdad T.

AU - Lainhart, William D.

AU - Wiederhold, Nathan P.

AU - Al-Obaidi, Mohanad M.

PY - 2023/10/1

Y1 - 2023/10/1

N2 - The clinical utility of Coccidioides species antifungal susceptibility testing (AST) remains unclear. This study describes the clinical course of eight patients with severe or chronic coccidioidomycosis and subsequent Coccidioides AST. We present the clinical manifestations, antifungal treatment regimens, and clinical outcomes for these patients.

AB - The clinical utility of Coccidioides species antifungal susceptibility testing (AST) remains unclear. This study describes the clinical course of eight patients with severe or chronic coccidioidomycosis and subsequent Coccidioides AST. We present the clinical manifestations, antifungal treatment regimens, and clinical outcomes for these patients.

KW - antifungal susceptibility

KW - antifungal therapy

KW - coccidioidomycosis

UR - http://www.scopus.com/inward/record.url?scp=85174752289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85174752289&partnerID=8YFLogxK

U2 - 10.1093/mmy/myad104

DO - 10.1093/mmy/myad104

M3 - Article

C2 - 37804176

AN - SCOPUS:85174752289

SN - 1369-3786

VL - 61

JO - Medical mycology

JF - Medical mycology

IS - 10

M1 - myad104

ER -

Coccidioides species antifungal susceptibility testing: Experience from a large healthcare system in the endemic region

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this